首页> 美国卫生研究院文献>BMC Molecular Biology >Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells
【2h】

Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells

机译:人气道和外周细胞中尿激酶纤溶酶原激活剂受体变体的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundExpression of the urokinase plasminogen activator receptor (UPAR) has been shown to have clinical relevance in various cancers. We have recently identified UPAR as an asthma susceptibility gene and there is evidence to suggest that uPAR may be upregulated in lung diseases such as COPD and asthma. uPAR is a key receptor involved in the formation of the serine protease plasmin by interacting with uPA and has been implicated in many physiological processes including proliferation and migration. The current aim was to determine key regulatory regions and splice variants of UPAR and quantify its expression in primary human tissues and cells (including lung, bronchial epithelium (HBEC), airway smooth muscle (HASM) and peripheral cells).
机译:背景技术尿激酶纤溶酶原激活物受体(UPAR)的表达已显示在各种癌症中具有临床意义。我们最近已将UPAR鉴定为哮喘易感基因,并且有证据表明uPAR在肺部疾病(如COPD和哮喘)中可能被上调。 uPAR是通过与uPA相互作用参与丝氨酸蛋白酶纤溶酶形成的关键受体,并已参与许多生理过程,包括增殖和迁移。当前的目标是确定UPAR的关键调控区域和剪接变体,并定量其在主要人类组织和细胞(包括肺,支气管上皮(HBEC),气道平滑肌(HASM)和外周细胞)中的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号